For example, in some prostate cancer cells, reduced ORAI1-mediated Ca2+ influx occurs and may bestow resistance to some apoptotic pathways [26], whereas in some breast cancer cells, augmentation of ORAI1-mediated Ca2+ influx appears to contribute to migration and proliferation pathways [60]. This evidence concerns the gene ORAI1 and prostate carcinoma.